Efficacy Analyses News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Efficacy Analyses. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Efficacy Analyses Today - Breaking & Trending Today

Trevi Therapeutics Reports Statistically Significant Result on Interim Analysis from the Ph2 CANAL Trial of Nalbuphine ER in the Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis

Published: February 24, 2022

/PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI) today announced positive interim analysis results of the Phase 2 Cough And NALbuphine (CANAL) trial of...

Source: prnewswire.com

Related Topics:

United StatesUnited KingdomRosalia ScampoliKatie McmanusToby MaherExchange CommissionHealth AuthoritiesUniversity Of Southern CaliforniaTrevi Therapeutics IncBill ForbesChief Development OfficerInterstitial Lung DiseaseKeck SchoolPrimary Efficacy Endpoint AnalysisFull AnalysisAnalysis SetEfficacy AnalysesTreatment PeriodTolerability ResultsChronic CoughIdiopathic PulmonaryTrevi TherapeuticsNew HavenFast TrackPrivate Securities Litigation Reform Act